Male menopausal symptoms
Conditions
Interventions
None listed
Sponsors
FANCL Corporation
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1)Japanese male aged 20 to 75 at the time of informed consent. 2)Subjects who made a visit to outpatient clinic for male menopause and are diagnosed not to need medication for male menopause symptoms. 3) Subjects who need watch and wait and decide to use health food and the like by their own will for the purpose of nutrition support that is insufficient in the diet.. 4) Subjects who will intake the compound supplements.
Exclusion criteria
Exclusion criteria: 1)Subjects who are suspected to have serious disease such as digestive, liver, kidney, circulatory, blood, and endocrine disorder or who have the history of these disorders. 2) Subjects who are judged to require testosterone replacement therapy at outpatient clinic 3)Subjects who are judged to require administration of PDE-5 inhibitor at outpatient clinic 4)Subjects who are judged to require the administration of antidepressants or anti-anxiety drug at outpatient clinics 5)Subjects who are currently taking a supplement which contains a same functional substance as the compound supplements 6)Subjects who may cause allergic reactions to foods 7)Subjects who are heavy smoker or heavy user of alcohol 8)Subjects who are judged as unsuitable for the study by the investigator with other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in fatigue VAS after ingestion of the supplements for 8 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in AMS score anti aging,QOL total blood testosterone and free blood testosteronea after ingestion of the supplements for 8 weeks. | — |
Countries
Japan
Contacts
Public ContactIsao Takehara
Clinical Support Corpration Food Service Division
Outcome results
None listed